Competitive intel on demand
Landscape questions used to mean weeks of manual research. Ask who holds authorisations for a molecule, where, and at what stage, and get a structured, sourced answer the same afternoon, built from public regulatory data and your own portfolio.
A BD question becomes a sourced landscape
Who holds authorisations for this molecule, and which markets are still open?
Used to mean weeks of register research
DE · FR
Generic filing
EU-wide
Originator A
PL
Open market
NL
Open market
Outcome
Sourced answer the same afternoon
One question in, one structured answer out: who holds what, where the competition is moving, and which markets are still open.
Landscape answers take a quarter, and they're stale on arrival
Mapping who holds what across markets means trawling agency registers and procedure databases by hand. The work is expensive and slow, and the result is out of date almost as soon as it lands. So business decisions get made on partial pictures or gut feel.
From a question to a structured landscape
Ask the question
Pose it the way a BD question sounds: a molecule, a market, a therapeutic area, a competitor.
Workbench assembles the answer
It draws on public regulatory data and your own portfolio context to build a structured view of who holds what, where, and at what stage.
Get a sourced, shareable result
A clear landscape you can act on and share, with the sources behind each entry so it stands up to scrutiny.
Ask a landscape question and get a sourced answer
A real BD question becomes a short, defensible market landscape your team can share.
For this molecule, who is authorised in the EU, where is generic activity visible, and which target markets still look open?
Executive summary
Short answer: PL and NL are the two markets worth validating first. Treating the whole EU as one opportunity would hide the fact that competitive activity is already clustering elsewhere.
Originator A still holds the incumbent position across the checked markets. Generic B is clearly moving through DCP in DE/FR, but the same filing signal does not show up in PL or NL.
Practical next step: send PL and NL to commercial validation with a note to check tender dynamics and reimbursement timing before either market moves into the launch model.
Competitive landscape brief
Each recommendation carries its reasoning and a source trail, so the result can go straight to RA, BD or the product owner.
Review notes
Intelligence at the speed of the decision
An afternoon, not a quarter
Answers arrive while the question still matters and the opportunity is still open.
Sourced and checkable
Built from real regulatory data and your portfolio, with traceable sources behind every claim.
Re-runnable on demand
Refresh the landscape whenever you need it, so your view stays current as filings change.
A landscape review that used to be a consulting engagement now takes an afternoon.
Get the landscape this afternoon
See how Regunaut answers competitive and regulatory landscape questions on demand.